Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xerecept in pediatric CNS tumors
NCT01369121Phase 2Terminated
- Sponsor
- Celtic Pharma
- Start
- Jun 2010
- Primary completion
- Oct 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of corticorelin ovine triflutate in Peritumoral brain edema (PTBE), sponsored by Celtic Pharma. Started Jun 2010; status: terminated.
02
Drugs
corticorelin ovine triflutate
03
Conditions
Peritumoral brain edema (PTBE)
Beyond the preview
Go deeper on NCT01369121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01369121.